Diuretic-hypotensive therapy and fetal prognosis in toxaemia of pregnancy. 1. Fetal prognosis in 705 selected cases.
D000086:Acetazolamide / Q000627:therapeutic use; D000643:Ammonium Chloride / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001463:Barbiturates / Q000627:therapeutic use; D001724:Birth Weight; D002740:Chlorothiazide / Q000627:therapeutic use; D036861:Delivery, Obstetric; D004039:Diet, Sodium-Restricted; D004232:Diuretics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005313:Fetal Death; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D007226:Infant Mortality; D007231:Infant, Newborn; D008274:Magnesium / Q000627:therapeutic use; D010710:Phosphates / Q000627:therapeutic use; D011225:Pre-Eclampsia / Q000188:drug therapy / Q000628:therapy*; D011247:Pregnancy; D011379:Prognosis; D011526:Protoveratrines / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use
D000959:Antihypertensive Agents; D001463:Barbiturates; D004232:Diuretics; D010710:Phosphates; D011526:Protoveratrines; D000643:Ammonium Chloride; D006830:Hydralazine; D002740:Chlorothiazide; D012110:Reserpine; D008274:Magnesium; D000086:Acetazolamide